r.i. pharamaceuticals
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 17 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 61 bids — ROYAL BIOTECH appeared in 12 of them.
R.I. PHARAMACEUTICALS
R.I. PHARAMACEUTICALS
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
188
Contract Value
₹3.39 Cr
L1 Bids
117
Recent Win Rate
73.7%
Performance Analytics
R.I. PHARMACEUTICALS Government Tender Profile: A Business Analysis Report
R.I. PHARMACEUTICALS stands out with a strong 62.2% win rate in government tenders, showcasing robust financial performance and strategic market positioning. This analysis delves into their success factors, competitive advantages, and areas for improvement in the pharmaceuticals business analysis landscape.
Executive Summary
R.I. PHARMACEUTICALS exhibits strong government tender performance, securing a remarkable 62.2% success rate from 188 bids, translating to 117 L1 wins. Their financial growth is evident in securing ₹3,39,07,627.0 in government contract value. A solid technical qualification rate of 85.6% further underpins their competence. This report assesses their competitive positioning within the pharmaceutical sector and recommends strategies for sustainable growth.
Financial Performance Analysis of R.I. PHARMACEUTICALS
An in-depth look into the financial metrics of R.I. PHARMACEUTICALS reveals both strengths and areas for optimization. This section highlights key financials and provides a pharmaceuticals business analysis perspective.
Key Financial Metrics
- Total Bids: 188